...
首页> 外文期刊>Oncology research and treatment. >Volumetric Modulated Arc Therapy versus Fixed-Field Intensity-Modulated Radiotherapy in Radical Irradiation for Cervical Cancer without Lymphadenectasis: Dosimetric and Clinical Results
【24h】

Volumetric Modulated Arc Therapy versus Fixed-Field Intensity-Modulated Radiotherapy in Radical Irradiation for Cervical Cancer without Lymphadenectasis: Dosimetric and Clinical Results

机译:体积调制的弧治疗与固定场强度调制放射治疗,用于宫颈癌的根治性辐照,没有淋巴结肌瘤:剂量测定和临床结果

获取原文
获取原文并翻译 | 示例

摘要

Background: The aim of this study was to compare the dosimetric parameters, clinical complications, and efficacy of volumetric modulated arc therapy (VMAT) and fixed-field intensity-modulated radiotherapy (f-IMRT) in radical radiotherapy for cervical cancer without lymphadenectasis. Methods: 84 cervical cancer patients undergoing treatment with VMAT and f-IMRT were selected. Dose-volume histograms were used to evaluate the dose distribution in the planning target volume (PTV) and organs at risk. The clinical complications and efficacy were observed. Results: The homogeneity index (HI) and the conformity index (CI) of VMAT plans were both superior to the HI and CI of f-IMRT plans (p = 0.043, 0.025). VMAT plans resulted in a reduction in the V30 of the rectum and V40 of the bladder (p = 0.002). Furthermore, the monitor units (MUs) for VMAT were less than a quarter of those for f-IMRT. The treatment time for VMAT was less than a half of that for f-IMRT. Both clinical complications and efficacy showed no significant differences. Conclusion: VMAT plans showed superior dose coverage of the PTV, better protection of the rectum and bladder in dosimetry, and significantly reduced MUs and treatment time compared with f-IMRT. Clinical results were similar for both plans. (c) 2018 S. Karger GmbH, Freiburg
机译:背景:本研究的目的是将体积调制弧治疗(VMAT)和固定场强度调制的放射治疗(F-IMRT)的临床放射治疗(F-IMRT)进行比较,用于宫颈癌,无淋巴结癌。方法:选择84例经历VMAT和F-IMRT治疗的宫颈癌患者。使用剂量直方图评估规划靶体积(PTV)和风险的器官的剂量分布。观察到临床并发症和疗效。结果:VMAT计划的同质性指数(HI)和符合性指数(CI)都优于F-IMRT计划的HI和CI(P = 0.043,0.025)。 VMAT计划导致膀胱的直肠和V40的V30减少(p = 0.002)。此外,VMAT的监测单元(MU)小于F-IMRT的四分之一。对于F-IMRT,VMAT的治疗时间少于一半。临床并发症和功效都没有显着差异。结论:VMAT计划显示出PTV的优异剂量覆盖,更好地保护直肠和膀胱在剂量测定中,与F-IMRT相比,MUS和治疗时间显着降低。两个计划都相似的临床结果。 (c)2018年S. Karger GmbH,Freiburg

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号